were revealed as the recruitment of host macrophages by the tumor cells was found to be the source of 39 the tumor MMP-2/-9 activity and it is evident that MMP-2/-9 from both host and tumor is required for 40 maximum signal using RACPP imaging for detection. We conclude that in the PyVmT model, the 41 majority of MMP-2/-9 activity in mammary tumors is associated with host macrophages recruited into Introduction source of MMP-2/-9 activity, we examined their infiltration into tumors. 
179
Although no significant difference in survival of weaned male and female DKO mice was 180 observed, we found mild but significant early growth retardation in DKOs of both sexes ( Figure S1 ), 181 which has not been observed in single KO mice. Male DKO mice were more compromised at an early 182 age compared with their WT counterparts (~57% reduction in body weight at 3-6 weeks, recovering to 183 86% by 12 weeks; Figure S1A ) than female DKO mice (~84% reduction in body weight from week 6; 184 Figure S1B ), underscoring the important role MMP-2/-9 play in normal development. The importance of MMP-2/-9 in the tumor cells was more apparent at the microscopic level, as WT 320 tumor cells implanted in WT mice had higher ratios than those implanted in DKO mice (4.35 ± 0.25 and 321 3.34 ± 0.24, respectively, p = 0.01), indicating that more subtle differences could be detected with 322 higher magnification ( Figure 4A,B) . In contrast, the ratios for DKO tumors in either WT or DKO mice 323 were not significantly different (2.13 ± 0.12 and 2.16 ± 0.13, respectively; p = 0.87). MMP-2/-9 324 expression in mammary carcinoma cells is associated with epithelial to mesenchymal transition and 325 increased tumor cell invasivesness (41), so it is not surprising that our invasive WT cell line affects the 326 RACPP ratios more than the DKO cell line. Importantly, our RACPP findings were consistent at both 327 the macroscopic and microscopic levels. MMP-2/-9 activatable RACPPs coupled with 328 chemotherapeutic agents have been shown to be effective in reducing breast cancer burden in animal 14 329 models (42). Our results suggest this efficacy is due in part to the ability of these agents to target both 330 tumor cells and their associated tumor-promoting stroma.
331
In addition to examining the ratios at a microscopic level, we examined the tumor morphology 332 after H&E staining and found that while the WT tumors were dense with tumor cells, the DKO tumors 333 had a looser tissue organization ( Figure 4A ). The differences in growth rates, which reflect tumor 334 heterogeneity and different mammary tumor subtypes explains the differences in their morphology (18). We also evaluated the number of neutrophils, which produce MMP-2/-9, in tumor sections 386 ( Figure S3 ). Neutrophils were a potential candidate cell type contributing to additional activity in the WT 387 tumor in WT mice because neutrophils secrete MMP-9 without tissue inhibitor metalloproteinase 1 388 (TIMP-1), whereas many other cell types secrete MMP-9 and TIMP-1 together(45 Table S1 . Breeding results for production of MMP-2 and -9 double KO mice. * p < 0.05 Chi-square test.
549
The number of pups reflects those surviving to weaning at 3 weeks of age. 
